Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatriz Montaner

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Toxicology Letters|March 7, 2002
The cytotoxic prodigiosin induces phosphorylation of p38-MAPK but not of SAPK/JNKBeatriz Montaner, Ricardo Pérez-Tomás
Annals of the New York Academy of Sciences|December 18, 2002
Prodigiosin induces caspase-9 and caspase-8 activation and cytochrome C release in Jurkat T cellsBeatriz Montaner, Ricardo Perez-Tomas
Current Cancer Drug Targets|February 7, 2003
The prodigiosins: a new family of anticancer drugsBeatriz Montaner, Ricardo Pérez-Tomás
Biochemical Pharmacology|February 21, 2002
Activation of protein kinase C for protection of cells against apoptosis induced by the immunosuppressor prodigiosinBeatriz Montaner Ramoneda, Ricardo Pérez-Tomás
Biochemical Pharmacology|October 14, 2003
The prodigiosins, proapoptotic drugs with anticancer propertiesRicardo Pérez-Tomás, Beatriz Montaner, Esther Llagostera, et al.
Annals of the New York Academy of Sciences|March 23, 2004
Prodigiosin induces apoptosis by acting on mitochondria in human lung cancer cellsEsther Llagostera, Vanessa Soto-Cerrato, Beatriz Montaner, et al.
Biochemical Pharmacology|September 4, 2004
Mitochondria-mediated apoptosis operating irrespective of multidrug resistance in breast cancer cells by the anticancer agent prodigiosinVanessa Soto-Cerrato, Esther Llagostera, Beatriz Montaner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 28, 2017
The Small Rho GTPase TC10 Modulates B Cell Immune ResponsesMarianne Burbage, Selina J Keppler, Beatriz Montaner, et al.
Biochemical Pharmacology|November 22, 2005
Cell cycle arrest and proapoptotic effects of the anticancer cyclodepsipeptide serratamolide (AT514) are independent of p53 status in breast cancer cellsVanessa Soto-Cerrato, Beatriz Montaner, Marc Martinell, et al.
Investigational New Drugs|April 25, 2006
Proteomic analysis of prodigiosin-induced apoptosis in a breast cancer mitoxantrone-resistant (MCF-7 MR) cell lineMarta Monge, Marta Vilaseca, Vanessa Soto-Cerrato, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Toxicology Letters|March 7, 2002
The cytotoxic prodigiosin induces phosphorylation of p38-MAPK but not of SAPK/JNKBeatriz Montaner, Ricardo Pérez-Tomás
Annals of the New York Academy of Sciences|December 18, 2002
Prodigiosin induces caspase-9 and caspase-8 activation and cytochrome C release in Jurkat T cellsBeatriz Montaner, Ricardo Perez-Tomas
Current Cancer Drug Targets|February 7, 2003
The prodigiosins: a new family of anticancer drugsBeatriz Montaner, Ricardo Pérez-Tomás
Biochemical Pharmacology|February 21, 2002
Activation of protein kinase C for protection of cells against apoptosis induced by the immunosuppressor prodigiosinBeatriz Montaner Ramoneda, Ricardo Pérez-Tomás
Biochemical Pharmacology|October 14, 2003
The prodigiosins, proapoptotic drugs with anticancer propertiesRicardo Pérez-Tomás, Beatriz Montaner, Esther Llagostera, et al.
Annals of the New York Academy of Sciences|March 23, 2004
Prodigiosin induces apoptosis by acting on mitochondria in human lung cancer cellsEsther Llagostera, Vanessa Soto-Cerrato, Beatriz Montaner, et al.
Biochemical Pharmacology|September 4, 2004
Mitochondria-mediated apoptosis operating irrespective of multidrug resistance in breast cancer cells by the anticancer agent prodigiosinVanessa Soto-Cerrato, Esther Llagostera, Beatriz Montaner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 28, 2017
The Small Rho GTPase TC10 Modulates B Cell Immune ResponsesMarianne Burbage, Selina J Keppler, Beatriz Montaner, et al.
Biochemical Pharmacology|November 22, 2005
Cell cycle arrest and proapoptotic effects of the anticancer cyclodepsipeptide serratamolide (AT514) are independent of p53 status in breast cancer cellsVanessa Soto-Cerrato, Beatriz Montaner, Marc Martinell, et al.
Investigational New Drugs|April 25, 2006
Proteomic analysis of prodigiosin-induced apoptosis in a breast cancer mitoxantrone-resistant (MCF-7 MR) cell lineMarta Monge, Marta Vilaseca, Vanessa Soto-Cerrato, et al.
Pageof 3